$4.94
-0.43-8.01%
마지막 업데이트: Oct 30, 8:42 AM
Benzinga
Benzinga
Benzinga
토요일, 10월 31
Benzinga
© 2026 Benzinga | All Rights Reserved
aTyr Pharma (ATYR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.15 | $-0.18 | $-0.19 |
| Actual | $-0.11 | $-0.11 | $-0.14 | $-0.26 |
| Surprise | +8.33% | +26.7% | +22.2% | -36.8% |
| Revenue | ||||
| Estimate | — | $20000 | $20000 | $4.8M |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | -100.0% | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-4.08 | $-3.94 | $-6.40 | $-6.00 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $-0.11 | $-0.12 | 8.33 % |
| Q1 | May 15, 2026 | $-0.11 | $-0.15 | 26.7 % |
| Q4 | Mar 5, 2026 | $-0.14 | $-0.18 | 22.2 % |
| Q3 | Nov 6, 2025 | $-0.26 | $-0.19 | -36.8 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q1 | May 15, 2026 | $0 | $20.00K | -100.0 % |
| Q4 | Mar 5, 2026 | $0 | $20.00K | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $4.80M | -100.0 % |
| Q3 | Nov 7, 2024 | $0 | $20.00K | -100.0 % |